Fortitude Family Office’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.74K	Sell	158 -19	-11%	-$210	﹤0.01%	1265
2025 Q1	$1.58K	Hold	177	–	–	﹤0.01%	956
2024 Q4	$1.67K	Buy	+177	New	+$1.67K	﹤0.01%	1061
2024 Q1	–	Sell	-441	Closed	-$4.96K	–	1081
2023 Q4	$4.96K	Buy	+441	New	+$4.96K	﹤0.01%	641